Repeat retroperitoneal lymph‐node dissection after chemotherapy for metastatic testicular germ cell tumour

To examine the operative findings, histopathology and clinical outcome of patients undergoing repeat retroperitoneal lymph node dissection (RPLND) after initial chemotherapy and RPLND (PC‐RPLND) for metastatic testicular germ cell tumour (GCT), as a small proportion relapse or have residual disease after incomplete resection in the lung, retrocrural or pelvic nodes, and retroperitoneum.

[1]  J. Gale,et al.  Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure , 2006, BJU international.

[2]  A. Horwich,et al.  Guidelines on testicular cancer. , 2005, European urology.

[3]  A. Heidenreich,et al.  Repeat retroperitoneal lymphadenectomy in advanced testicular cancer. , 2005, European urology.

[4]  W. Siegert,et al.  European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  P. Albers,et al.  Late relapse of testicular cancer , 2004, World Journal of Urology.

[6]  J. Bacik,et al.  Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome. , 2003, Urology.

[7]  P. Albers,et al.  Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. , 2003, The Journal of urology.

[8]  C. Wood,et al.  Repeat retroperitoneal lymph node dissection for metastatic testis cancer. , 2003, The Journal of urology.

[9]  S. Fosså,et al.  Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Dearnaley,et al.  Metastatic nonseminomatous germ cell tumors of the testis , 2002, Cancer.

[11]  J. Donohue,et al.  Integration of surgery and systemic therapy: results and principles of integration. , 1998, Seminars in urologic oncology.

[12]  T. Christmas,et al.  Excision of residual masses of metastatic germ cell tumours after chemotherapy: the role of extraperitoneal surgical approaches. , 1998, British journal of urology.

[13]  R. Ravi.  Growing teratoma syndrome. , 1995, Urologia internationalis.

[14]  E. Messing,et al.  Redo retroperitoneal lymphadenectomy for germ cell tumor. , 1993, Urology.

[15]  F. Debruyne,et al.  Nerve-sparing retroperitoneal lymphadenectomy for low stage testicular cancer. , 1993, British journal of urology.

[16]  S. Fosså,et al.  Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  T. Ulbright,et al.  The development of non‐germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases , 1984, Cancer.